To elucidate the role of N - glycosylation in the functional activity of the universal glucose transporter, Glut - 1, we investigated effects of the N - glycosylation inhibitor, tunicamycin, on glucose transport by human leukemic cell lines K562, U937 and HL60.	"glucose	87	94	Chemical"	"Glut - 1	108	116	Gene_or_gene_product"	"tunicamycin	178	189	Chemical"	"glucose	194	201	Chemical"	"human	215	220	Organism"	"leukemic cell lines K562	221	245	Cell"	"U937	247	251	Cell"	"HL60	256	260	Cell"	"[{""token"": ""glucose"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""Glut - 1"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""tunicamycin"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 194, ""end_span"": 201, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 215, ""end_span"": 220, ""type"": ""Organism""}, {""token"": ""leukemic cell lines K562"", ""start_span"": 221, ""end_span"": 245, ""type"": ""Cell""}, {""token"": ""U937"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Cell""}, {""token"": ""HL60"", ""start_span"": 256, ""end_span"": 260, ""type"": ""Cell""}]"
Since AP - 1 and NF - kappa B are key elements in controlling interleukin - 8 ( IL - 8) transcription, human fibroblasts were treated with alpha - MSH and IL - 1 beta for 24 hours, and cytokine levels in the supernatants were measured by ELISA.	"AP - 1	6	12	Gene_or_gene_product"	"NF - kappa B	17	29	Gene_or_gene_product"	"interleukin - 8	62	77	Gene_or_gene_product"	"IL - 8	80	86	Gene_or_gene_product"	"human	103	108	Organism"	"fibroblasts	109	120	Cell"	"alpha - MSH	139	150	Gene_or_gene_product"	"IL - 1 beta	155	166	Gene_or_gene_product"	"[{""token"": ""AP - 1"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappa B"", ""start_span"": 17, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 8"", ""start_span"": 62, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""alpha - MSH"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1 beta"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}]"
Here we show that IL - 12 activates an anti - angiogenic program in Con A - activated mouse spleen cells ( activated spc) or human PBMC ( activated PBMC).	"IL - 12	18	25	Gene_or_gene_product"	"Con A	68	73	Chemical"	"mouse	86	91	Organism"	"spleen cells	92	104	Cell"	"spc	117	120	Cell"	"human	125	130	Organism"	"PBMC	131	135	Cell"	"PBMC	148	152	Cell"	"[{""token"": ""IL - 12"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Con A"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Chemical""}, {""token"": ""mouse"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""spleen cells"", ""start_span"": 92, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""spc"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Organism""}, {""token"": ""PBMC"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Cell""}, {""token"": ""PBMC"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Cell""}]"
Experiments with nu / nu mice, nonobese diabetic - SCID mice, or activated spc enriched in specific cell subpopulations demonstrated that CD4 ( +), CD8 ( +), and NK cells are all needed to mediate the full anti - angiogenetic effect of IL - 12.	"nu / nu mice	17	29	Organism"	"nonobese diabetic - SCID mice	31	60	Organism"	"spc	75	78	Cell"	"cell	100	104	Cell"	"CD4	138	141	Gene_or_gene_product"	"CD8	148	151	Gene_or_gene_product"	"NK cells	162	170	Cell"	"IL - 12	236	243	Gene_or_gene_product"	"[{""token"": ""nu / nu mice"", ""start_span"": 17, ""end_span"": 29, ""type"": ""Organism""}, {""token"": ""nonobese diabetic - SCID mice"", ""start_span"": 31, ""end_span"": 60, ""type"": ""Organism""}, {""token"": ""spc"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""CD4"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD8"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""NK cells"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Cell""}, {""token"": ""IL - 12"", ""start_span"": 236, ""end_span"": 243, ""type"": ""Gene_or_gene_product""}]"
To observe the influence of fungus polysaccharides compounds ( FPC) in inducing human liver cancer cell Bel - 7402 apoptosis in cell cultivating in vitro, the authors analyzed tumor inhibitive gene P53 expression in Bel - 7402 apoptosis by applying double immuno - marker.	"fungus polysaccharides compounds	28	60	Chemical"	"FPC	63	66	Chemical"	"human	80	85	Organism"	"liver cancer cell Bel - 7402	86	114	Cell"	"cell	128	132	Cell"	"tumor	176	181	Cancer"	"P53	198	201	Gene_or_gene_product"	"Bel - 7402	216	226	Cell"	"[{""token"": ""fungus polysaccharides compounds"", ""start_span"": 28, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""FPC"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""liver cancer cell Bel - 7402"", ""start_span"": 86, ""end_span"": 114, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Cancer""}, {""token"": ""P53"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bel - 7402"", ""start_span"": 216, ""end_span"": 226, ""type"": ""Cell""}]"
Twenty - one patients underwent resection of the remnant stomach for RSC and were divided into two groups: the RSCB group consisted of 11 patients who underwent distal gastrectomy for benign disease and the RSCM group consisted of 10 patients who underwent gastrectomy for primary gastric cancer.	"patients	13	21	Organism"	"remnant stomach	49	64	Organ"	"RSC	69	72	Cancer"	"RSCB	111	115	Cancer"	"patients	138	146	Organism"	"RSCM	207	211	Cancer"	"patients	234	242	Organism"	"gastric cancer	281	295	Cancer"	"[{""token"": ""patients"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Organism""}, {""token"": ""remnant stomach"", ""start_span"": 49, ""end_span"": 64, ""type"": ""Organ""}, {""token"": ""RSC"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Cancer""}, {""token"": ""RSCB"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 138, ""end_span"": 146, ""type"": ""Organism""}, {""token"": ""RSCM"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 234, ""end_span"": 242, ""type"": ""Organism""}, {""token"": ""gastric cancer"", ""start_span"": 281, ""end_span"": 295, ""type"": ""Cancer""}]"
A specific histone deacetylase ( HDAc) inhibitor, trichostatin A ( TSA), alleviates Evi - 1 - mediated repression of TGF - beta signaling, suggesting that HDAc is involved in transcriptional repression by Evi - 1.	"histone deacetylase	11	30	Gene_or_gene_product"	"HDAc	33	37	Gene_or_gene_product"	"trichostatin A	50	64	Chemical"	"TSA	67	70	Chemical"	"Evi - 1	84	91	Gene_or_gene_product"	"TGF - beta	117	127	Gene_or_gene_product"	"HDAc	155	159	Gene_or_gene_product"	"Evi - 1	205	212	Gene_or_gene_product"	"[{""token"": ""histone deacetylase"", ""start_span"": 11, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""HDAc"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""trichostatin A"", ""start_span"": 50, ""end_span"": 64, ""type"": ""Chemical""}, {""token"": ""TSA"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Chemical""}, {""token"": ""Evi - 1"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 117, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""HDAc"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi - 1"", ""start_span"": 205, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}]"
The non - invasive human melanoma cell line, IF6, which does not express uPA, provided further confirmation of PAI - 1 and uPA ' s role as, upon transfection with uPA, this cell line attained an invasive phenotype, which was again attenuated by MAI - 12.	"human	19	24	Organism"	"melanoma cell line	25	43	Cell"	"IF6	45	48	Cell"	"uPA	73	76	Gene_or_gene_product"	"PAI - 1	111	118	Gene_or_gene_product"	"uPA	123	126	Gene_or_gene_product"	"uPA	163	166	Gene_or_gene_product"	"cell line	173	182	Cell"	"[{""token"": ""human"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Organism""}, {""token"": ""melanoma cell line"", ""start_span"": 25, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""IF6"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""uPA"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAI - 1"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPA"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPA"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell line"", ""start_span"": 173, ""end_span"": 182, ""type"": ""Cell""}]"
Since congenital neutropenia and SDS are inherited forms of bone marrow failure, G - CSF may accelerate the propensity for MDS / AML in the genetically altered stem and progenitor cells, especially in those with G - CSF receptor and ras mutations ( 82% and 50% of patients who transform, respectively).	"bone marrow	60	71	Multi"	"G - CSF	81	88	Gene_or_gene_product"	"AML	129	132	Cancer"	"stem	160	164	Cell"	"progenitor cells	169	185	Cell"	"G - CSF receptor	212	228	Gene_or_gene_product"	"ras	233	236	Gene_or_gene_product"	"patients	264	272	Organism"	"[{""token"": ""bone marrow"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Multi""}, {""token"": ""G - CSF"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""AML"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Cancer""}, {""token"": ""stem"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Cell""}, {""token"": ""progenitor cells"", ""start_span"": 169, ""end_span"": 185, ""type"": ""Cell""}, {""token"": ""G - CSF receptor"", ""start_span"": 212, ""end_span"": 228, ""type"": ""Gene_or_gene_product""}, {""token"": ""ras"", ""start_span"": 233, ""end_span"": 236, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 264, ""end_span"": 272, ""type"": ""Organism""}]"
Western blotting of p53 and murine double mutant 2 ( Mdm2) together with p53 DNA sequencing analysis indicate that p53 function loss by mutation or overexpression of Mdm2 occurred in all tested oral cancer cells regardless of their etiology.	"p53	20	23	Gene_or_gene_product"	"murine double mutant 2	28	50	Gene_or_gene_product"	"Mdm2	53	57	Gene_or_gene_product"	"p53	73	76	Gene_or_gene_product"	"DNA	77	80	Cellular_component"	"p53	115	118	Gene_or_gene_product"	"Mdm2	166	170	Gene_or_gene_product"	"oral cancer cells	194	211	Cell"	"[{""token"": ""p53"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine double mutant 2"", ""start_span"": 28, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mdm2"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Cellular_component""}, {""token"": ""p53"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mdm2"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""oral cancer cells"", ""start_span"": 194, ""end_span"": 211, ""type"": ""Cell""}]"
The tumors of A431 supplemented with F - 2 cells were profoundly vascularized throughout by the tubular structures formed by F - 2 cells, the lumen of which contained the host rat blood cells.	"tumors	4	10	Cancer"	"A431	14	18	Cell"	"F - 2 cells	37	48	Cell"	"tubular structures	96	114	Tissue"	"F - 2 cells	125	136	Cell"	"lumen	142	147	Immaterial_anatomical_entity"	"rat	176	179	Organism"	"blood cells	180	191	Cell"	"[{""token"": ""tumors"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Cancer""}, {""token"": ""A431"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Cell""}, {""token"": ""F - 2 cells"", ""start_span"": 37, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""tubular structures"", ""start_span"": 96, ""end_span"": 114, ""type"": ""Tissue""}, {""token"": ""F - 2 cells"", ""start_span"": 125, ""end_span"": 136, ""type"": ""Cell""}, {""token"": ""lumen"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""rat"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Organism""}, {""token"": ""blood cells"", ""start_span"": 180, ""end_span"": 191, ""type"": ""Cell""}]"
To investigate whether bee venom ( BV) induces apoptosis, the 3 - ( 4, 5 - dimethylthiazol - 2 - yl) - 2, 5 - diphenyltetrazolium bromide assay, terminal deoxynucleotidyl transferase - mediated dUTP nick end - labeling assay, 4, 6 - diamidino - 2 - phenylindole staining, flow cytometric analysis, and DNA fragmentation assay were performed on NCI - H1299 lung cancer cells treated with BV.	"bee	23	26	Organism"	"venom	27	32	Organism_substance"	"BV	35	37	Organism_substance"	"terminal deoxynucleotidyl transferase	145	182	Gene_or_gene_product"	"dUTP	194	198	Chemical"	"DNA	302	305	Cellular_component"	"NCI - H1299 lung cancer cells	344	373	Cell"	"BV	387	389	Organism_substance"	"[{""token"": ""bee"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Organism""}, {""token"": ""venom"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Organism_substance""}, {""token"": ""BV"", ""start_span"": 35, ""end_span"": 37, ""type"": ""Organism_substance""}, {""token"": ""terminal deoxynucleotidyl transferase"", ""start_span"": 145, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""dUTP"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 302, ""end_span"": 305, ""type"": ""Cellular_component""}, {""token"": ""NCI - H1299 lung cancer cells"", ""start_span"": 344, ""end_span"": 373, ""type"": ""Cell""}, {""token"": ""BV"", ""start_span"": 387, ""end_span"": 389, ""type"": ""Organism_substance""}]"
To determine whether changes in angiogenesis are responsible for the decrease in progesterone synthesis, we measured hemoglobin and CD34 levels in luteinized ovaries following injection of COX inhibitors and measured the relative frequency of cells positive for platelet - endothelial cell adhesion molecule as a specific marker for endothelial cells.	"progesterone	81	93	Chemical"	"hemoglobin	117	127	Gene_or_gene_product"	"CD34	132	136	Gene_or_gene_product"	"ovaries	158	165	Organ"	"COX	189	192	Gene_or_gene_product"	"cells	243	248	Cell"	"platelet - endothelial cell adhesion molecule	262	307	Gene_or_gene_product"	"endothelial cells	333	350	Cell"	"[{""token"": ""progesterone"", ""start_span"": 81, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""hemoglobin"", ""start_span"": 117, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD34"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovaries"", ""start_span"": 158, ""end_span"": 165, ""type"": ""Organ""}, {""token"": ""COX"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 243, ""end_span"": 248, ""type"": ""Cell""}, {""token"": ""platelet - endothelial cell adhesion molecule"", ""start_span"": 262, ""end_span"": 307, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 333, ""end_span"": 350, ""type"": ""Cell""}]"
Leukocyte - vessel wall interactions were studied both within and outside small tumors growing in the ear, and in ear microvessels of mice with a large tumor growing on their flank.	"Leukocyte	0	9	Cell"	"vessel wall	12	23	Multi"	"tumors	80	86	Cancer"	"ear	102	105	Organ"	"ear microvessels	114	130	Tissue"	"mice	134	138	Organism"	"tumor	152	157	Cancer"	"flank	175	180	Organism_subdivision"	"[{""token"": ""Leukocyte"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Cell""}, {""token"": ""vessel wall"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Multi""}, {""token"": ""tumors"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Cancer""}, {""token"": ""ear"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Organ""}, {""token"": ""ear microvessels"", ""start_span"": 114, ""end_span"": 130, ""type"": ""Tissue""}, {""token"": ""mice"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Cancer""}, {""token"": ""flank"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Organism_subdivision""}]"
The cell death pathway initiated by survivin targeting was mapped with respect to cytochrome c release, changes in mitochondrial transmembrane potential, and apoptosome requirements using mouse embryonic fibroblasts deficient in Apaf - 1 or caspase - 9.	"cell	4	8	Cell"	"survivin	36	44	Gene_or_gene_product"	"cytochrome c	82	94	Gene_or_gene_product"	"mitochondrial	115	128	Cellular_component"	"mouse	188	193	Organism"	"embryonic fibroblasts	194	215	Cell"	"Apaf - 1	229	237	Gene_or_gene_product"	"caspase - 9	241	252	Gene_or_gene_product"	"[{""token"": ""cell"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Cell""}, {""token"": ""survivin"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytochrome c"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 115, ""end_span"": 128, ""type"": ""Cellular_component""}, {""token"": ""mouse"", ""start_span"": 188, ""end_span"": 193, ""type"": ""Organism""}, {""token"": ""embryonic fibroblasts"", ""start_span"": 194, ""end_span"": 215, ""type"": ""Cell""}, {""token"": ""Apaf - 1"", ""start_span"": 229, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 9"", ""start_span"": 241, ""end_span"": 252, ""type"": ""Gene_or_gene_product""}]"
Granulocyte - macrophage colony - stimulating factor and interleukin - 3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.	"Granulocyte - macrophage colony - stimulating factor	0	52	Gene_or_gene_product"	"interleukin - 3	57	72	Gene_or_gene_product"	"cytosine arabinoside	102	122	Chemical"	"DNA	132	135	Cellular_component"	"leukemic blasts	139	154	Cell"	"clonogenic cells	183	199	Cell"	"patients	205	213	Organism"	"acute myeloid leukemia	219	241	Cancer"	"[{""token"": ""Granulocyte - macrophage colony - stimulating factor"", ""start_span"": 0, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 3"", ""start_span"": 57, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytosine arabinoside"", ""start_span"": 102, ""end_span"": 122, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Cellular_component""}, {""token"": ""leukemic blasts"", ""start_span"": 139, ""end_span"": 154, ""type"": ""Cell""}, {""token"": ""clonogenic cells"", ""start_span"": 183, ""end_span"": 199, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 205, ""end_span"": 213, ""type"": ""Organism""}, {""token"": ""acute myeloid leukemia"", ""start_span"": 219, ""end_span"": 241, ""type"": ""Cancer""}]"
Here, the pattern of expression of angiogenin during the transition from normal breast tissue to ductal carcinoma in situ and invasive carcinoma is reported together with the correlates between the level of angiogenin in 239 invasive carcinomas and standard clinicopathological parameters, hypoxia - inducible factor ( HIF) - 1 alpha and the HIF - 1 alpha target gene DEC - 1.	"angiogenin	35	45	Gene_or_gene_product"	"breast tissue	80	93	Tissue"	"ductal carcinoma	97	113	Cancer"	"carcinoma	135	144	Cancer"	"angiogenin	207	217	Gene_or_gene_product"	"carcinomas	234	244	Cancer"	"HIF - 1 alpha	342	355	Gene_or_gene_product"	"DEC - 1	368	375	Gene_or_gene_product"	"[{""token"": ""angiogenin"", ""start_span"": 35, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast tissue"", ""start_span"": 80, ""end_span"": 93, ""type"": ""Tissue""}, {""token"": ""ductal carcinoma"", ""start_span"": 97, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""carcinoma"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Cancer""}, {""token"": ""angiogenin"", ""start_span"": 207, ""end_span"": 217, ""type"": ""Gene_or_gene_product""}, {""token"": ""carcinomas"", ""start_span"": 234, ""end_span"": 244, ""type"": ""Cancer""}, {""token"": ""HIF - 1 alpha"", ""start_span"": 342, ""end_span"": 355, ""type"": ""Gene_or_gene_product""}, {""token"": ""DEC - 1"", ""start_span"": 368, ""end_span"": 375, ""type"": ""Gene_or_gene_product""}]"
Mutations in the genes encoding the three other succinate dehydrogenase subunits ( SDHB, SDHC and SDHD) have been identified in patients affected by familial or ' apparently sporadic ' paraganglioma and / or pheochromocytoma, an autosomal inherited cancer - susceptibility syndrome.	"succinate dehydrogenase	48	71	Gene_or_gene_product"	"SDHB	83	87	Gene_or_gene_product"	"SDHC	89	93	Gene_or_gene_product"	"SDHD	98	102	Gene_or_gene_product"	"patients	128	136	Organism"	"paraganglioma	185	198	Cancer"	"pheochromocytoma	208	224	Cancer"	"cancer	249	255	Cancer"	"[{""token"": ""succinate dehydrogenase"", ""start_span"": 48, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""SDHB"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""SDHC"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""SDHD"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Organism""}, {""token"": ""paraganglioma"", ""start_span"": 185, ""end_span"": 198, ""type"": ""Cancer""}, {""token"": ""pheochromocytoma"", ""start_span"": 208, ""end_span"": 224, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 249, ""end_span"": 255, ""type"": ""Cancer""}]"
The subsequent identification of germline mutations in the gene encoding fumarase - - another TCA cycle enzyme - - in a new hereditary form of susceptibility to renal, uterine and cutaneous tumors has highlighted the potential role of the TCA cycle and, more generally, of the mitochondria in cancer.	"fumarase	73	81	Gene_or_gene_product"	"TCA	94	97	Chemical"	"renal	161	166	Cancer"	"uterine	168	175	Cancer"	"cutaneous tumors	180	196	Cancer"	"TCA	239	242	Chemical"	"mitochondria	277	289	Cellular_component"	"cancer	293	299	Cancer"	"[{""token"": ""fumarase"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""TCA"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Chemical""}, {""token"": ""renal"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Cancer""}, {""token"": ""uterine"", ""start_span"": 168, ""end_span"": 175, ""type"": ""Cancer""}, {""token"": ""cutaneous tumors"", ""start_span"": 180, ""end_span"": 196, ""type"": ""Cancer""}, {""token"": ""TCA"", ""start_span"": 239, ""end_span"": 242, ""type"": ""Chemical""}, {""token"": ""mitochondria"", ""start_span"": 277, ""end_span"": 289, ""type"": ""Cellular_component""}, {""token"": ""cancer"", ""start_span"": 293, ""end_span"": 299, ""type"": ""Cancer""}]"
Two of these cell cycle inhibitors, p16 ( INK4A) and p15 ( INK4B), have tumor suppressor activities and are inactivated in human cancer.	"cell	13	17	Cell"	"p16	36	39	Gene_or_gene_product"	"INK4A	42	47	Gene_or_gene_product"	"p15	53	56	Gene_or_gene_product"	"INK4B	59	64	Gene_or_gene_product"	"tumor	72	77	Cancer"	"human	123	128	Organism"	"cancer	129	135	Cancer"	"[{""token"": ""cell"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""p16"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4A"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""p15"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4B"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Cancer""}]"
We also show that mouse p10 is able to inhibit foci formation and anchorage - independent growth in wild - type mouse embryonic fibroblasts, and that these antitransforming properties of mouse p10 are also p53 - dependent.	"mouse	18	23	Organism"	"p10	24	27	Gene_or_gene_product"	"foci	47	51	Cell"	"mouse	112	117	Organism"	"embryonic fibroblasts	118	139	Cell"	"mouse	187	192	Organism"	"p10	193	196	Gene_or_gene_product"	"p53	206	209	Gene_or_gene_product"	"[{""token"": ""mouse"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Organism""}, {""token"": ""p10"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""foci"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""mouse"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Organism""}, {""token"": ""embryonic fibroblasts"", ""start_span"": 118, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""mouse"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Organism""}, {""token"": ""p10"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"
This study examines the mechanism of HKa and D5 inhibition of two potent stimulators of endothelial cell migration, sphingosine 1 - phosphate ( S1P) and vascular endothelial growth factor ( VEGF), that act through the P13 - kinase - Akt signaling pathway.	"HKa	37	40	Gene_or_gene_product"	"endothelial cell	88	104	Cell"	"sphingosine 1 - phosphate	116	141	Gene_or_gene_product"	"S1P	144	147	Gene_or_gene_product"	"vascular endothelial growth factor	153	187	Gene_or_gene_product"	"VEGF	190	194	Gene_or_gene_product"	"P13 - kinase	218	230	Gene_or_gene_product"	"Akt	233	236	Gene_or_gene_product"	"[{""token"": ""HKa"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 88, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""sphingosine 1 - phosphate"", ""start_span"": 116, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""S1P"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 153, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}, {""token"": ""P13 - kinase"", ""start_span"": 218, ""end_span"": 230, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 233, ""end_span"": 236, ""type"": ""Gene_or_gene_product""}]"
Inhibitors of Akt and P13 - kinase, the upstream activator of Akt, block endothelial cell migration and disrupt paxillin localization to the focal adhesions after stimulation with VEGF and S1P.	"Akt	14	17	Gene_or_gene_product"	"P13 - kinase	22	34	Gene_or_gene_product"	"Akt	62	65	Gene_or_gene_product"	"endothelial cell	73	89	Cell"	"paxillin	112	120	Gene_or_gene_product"	"focal adhesions	141	156	Cellular_component"	"VEGF	180	184	Gene_or_gene_product"	"S1P	189	192	Gene_or_gene_product"	"[{""token"": ""Akt"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""P13 - kinase"", ""start_span"": 22, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 73, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""paxillin"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""focal adhesions"", ""start_span"": 141, ""end_span"": 156, ""type"": ""Cellular_component""}, {""token"": ""VEGF"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""S1P"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}]"
In this study, we used two inflammatory agents, IL - 1beta and phorbol myristic acetate, to activate PKC isozymes and specific inhibitors of PKCalpha ( Go6976) and PKCbeta ( hispidin) to distinguish how each of these isoform ( s) controls angiogenesis, wound healing, and permeability.	"IL - 1beta	48	58	Gene_or_gene_product"	"phorbol myristic acetate	63	87	Chemical"	"PKC	101	104	Gene_or_gene_product"	"PKCalpha	141	149	Gene_or_gene_product"	"Go6976	152	158	Chemical"	"PKCbeta	164	171	Gene_or_gene_product"	"hispidin	174	182	Chemical"	"wound	253	258	Pathological_formation"	"[{""token"": ""IL - 1beta"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""phorbol myristic acetate"", ""start_span"": 63, ""end_span"": 87, ""type"": ""Chemical""}, {""token"": ""PKC"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""PKCalpha"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""Go6976"", ""start_span"": 152, ""end_span"": 158, ""type"": ""Chemical""}, {""token"": ""PKCbeta"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""hispidin"", ""start_span"": 174, ""end_span"": 182, ""type"": ""Chemical""}, {""token"": ""wound"", ""start_span"": 253, ""end_span"": 258, ""type"": ""Pathological_formation""}]"
We show that LRP - 1 deficiency in murine embryonic fibroblasts ( MEFs) is associated with increased levels of type III collagen and pigment epithelium - derived factor, which accumulate in the substratum surrounding cells.	"LRP - 1	13	20	Gene_or_gene_product"	"murine	35	41	Organism"	"embryonic fibroblasts	42	63	Cell"	"MEFs	66	70	Cell"	"type III collagen	111	128	Gene_or_gene_product"	"pigment epithelium - derived factor	133	168	Gene_or_gene_product"	"substratum	194	204	Cellular_component"	"cells	217	222	Cell"	"[{""token"": ""LRP - 1"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Organism""}, {""token"": ""embryonic fibroblasts"", ""start_span"": 42, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""MEFs"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""type III collagen"", ""start_span"": 111, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""pigment epithelium - derived factor"", ""start_span"": 133, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""substratum"", ""start_span"": 194, ""end_span"": 204, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 217, ""end_span"": 222, ""type"": ""Cell""}]"
Methotrexate ( MTX), a folic acid antagonist widely used for the treatment of a variety of tumors and inflammatory diseases, affects normal tissues that have a high rate of proliferation, including the hematopoietic cells of the bone marrow and the gastrointestinal mucosal cells.	"Methotrexate	0	12	Chemical"	"MTX	15	18	Chemical"	"folic acid	23	33	Chemical"	"tumors	91	97	Cancer"	"normal tissues	133	147	Tissue"	"hematopoietic cells	202	221	Cell"	"bone marrow	229	240	Multi"	"gastrointestinal mucosal cells	249	279	Cell"	"[{""token"": ""Methotrexate"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""MTX"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""folic acid"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""tumors"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""normal tissues"", ""start_span"": 133, ""end_span"": 147, ""type"": ""Tissue""}, {""token"": ""hematopoietic cells"", ""start_span"": 202, ""end_span"": 221, ""type"": ""Cell""}, {""token"": ""bone marrow"", ""start_span"": 229, ""end_span"": 240, ""type"": ""Multi""}, {""token"": ""gastrointestinal mucosal cells"", ""start_span"": 249, ""end_span"": 279, ""type"": ""Cell""}]"
Here, we show that NCAM - deficient beta cell tumors grew leaky blood vessels with perturbed pericyte - endothelial cell - cell interactions and deficient perivascular deposition of ECM components.	"NCAM	19	23	Gene_or_gene_product"	"blood vessels	64	77	Multi"	"pericyte	93	101	Cell"	"endothelial	104	115	Cell"	"cell	116	120	Cell"	"cell	123	127	Cell"	"perivascular	155	167	Immaterial_anatomical_entity"	"ECM components	182	196	Cellular_component"	"[{""token"": ""NCAM"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessels"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Multi""}, {""token"": ""pericyte"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""endothelial"", ""start_span"": 104, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""perivascular"", ""start_span"": 155, ""end_span"": 167, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""ECM components"", ""start_span"": 182, ""end_span"": 196, ""type"": ""Cellular_component""}]"
RESULTS: Opticin was immunolocalised to the basal cell surface and basement membrane material of the non - pigmented CBE in nine donor eyes as well as four hyperplastic lesions of the CBE ( Fuchs ' s adenoma).	"Opticin	9	16	Gene_or_gene_product"	"basal cell surface	44	62	Cellular_component"	"basement membrane material	67	93	Cellular_component"	"non - pigmented CBE	101	120	Tissue"	"eyes	135	139	Organ"	"hyperplastic lesions	156	176	Cancer"	"CBE	184	187	Tissue"	"Fuchs ' s adenoma	190	207	Cancer"	"[{""token"": ""Opticin"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""basal cell surface"", ""start_span"": 44, ""end_span"": 62, ""type"": ""Cellular_component""}, {""token"": ""basement membrane material"", ""start_span"": 67, ""end_span"": 93, ""type"": ""Cellular_component""}, {""token"": ""non - pigmented CBE"", ""start_span"": 101, ""end_span"": 120, ""type"": ""Tissue""}, {""token"": ""eyes"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Organ""}, {""token"": ""hyperplastic lesions"", ""start_span"": 156, ""end_span"": 176, ""type"": ""Cancer""}, {""token"": ""CBE"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Tissue""}, {""token"": ""Fuchs ' s adenoma"", ""start_span"": 190, ""end_span"": 207, ""type"": ""Cancer""}]"
Compared with their corresponding single mutant littermates, the p18 ( - / -); Men1 ( + / -) mice develop tumors at an accelerated rate and with an increased incidence in the pituitary, thyroid, parathyroid, and pancreas.	"single mutant littermates	34	59	Organism"	"p18	65	68	Gene_or_gene_product"	"Men1	79	83	Gene_or_gene_product"	"tumors	106	112	Cancer"	"pituitary	175	184	Organ"	"thyroid	186	193	Organ"	"parathyroid	195	206	Organ"	"pancreas	212	220	Organ"	"[{""token"": ""single mutant littermates"", ""start_span"": 34, ""end_span"": 59, ""type"": ""Organism""}, {""token"": ""p18"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Cancer""}, {""token"": ""pituitary"", ""start_span"": 175, ""end_span"": 184, ""type"": ""Organ""}, {""token"": ""thyroid"", ""start_span"": 186, ""end_span"": 193, ""type"": ""Organ""}, {""token"": ""parathyroid"", ""start_span"": 195, ""end_span"": 206, ""type"": ""Organ""}, {""token"": ""pancreas"", ""start_span"": 212, ""end_span"": 220, ""type"": ""Organ""}]"
20 - HETE also increased the phosphorylation of p42 / p44 mitogen - activated protein kinase ( MAPK) in EC, whereas an inhibitor of MAPK [ U0126, 1, 4 - diamino - 2, 3 - dicyano - 1, 4 - bis ( 2 - aminophenylthio) butadiene] suppressed the proliferative and the VEGF changes but not the pro - oxidant effects of 20 - HETE.	"20 - HETE	0	9	Chemical"	"p42 / p44 mitogen - activated protein kinase	48	92	Gene_or_gene_product"	"MAPK	95	99	Gene_or_gene_product"	"EC	104	106	Cell"	"MAPK	132	136	Gene_or_gene_product"	"U0126	139	144	Chemical"	"VEGF	262	266	Gene_or_gene_product"	"20 - HETE	312	321	Chemical"	"[{""token"": ""20 - HETE"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""p42 / p44 mitogen - activated protein kinase"", ""start_span"": 48, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""MAPK"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""U0126"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 262, ""end_span"": 266, ""type"": ""Gene_or_gene_product""}, {""token"": ""20 - HETE"", ""start_span"": 312, ""end_span"": 321, ""type"": ""Chemical""}]"
Trib1 and Evi1 were up - regulated due to retroviral insertions, and coexpression of these genes significantly accelerated the onset of Hoxa9 / Meis1 - induced AML, suggesting that Trib1 and Evi1 are the key collaborators.	"Trib1	0	5	Gene_or_gene_product"	"Evi1	10	14	Gene_or_gene_product"	"retroviral	42	52	Organism"	"Hoxa9	136	141	Gene_or_gene_product"	"Meis1	144	149	Gene_or_gene_product"	"AML	160	163	Cancer"	"Trib1	181	186	Gene_or_gene_product"	"Evi1	191	195	Gene_or_gene_product"	"[{""token"": ""Trib1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi1"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""retroviral"", ""start_span"": 42, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""Hoxa9"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""Meis1"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""AML"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Cancer""}, {""token"": ""Trib1"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi1"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}]"
The v - Src - transformed MEFs deficient in SWAP - 70 were unable to grow in soft agar while those expressing SWAP70 readily formed colonies, suggesting that SWAP - 70 is required for anchorage independent growth of v - Src transformed MEFs.	"v - Src	4	11	Gene_or_gene_product"	"MEFs	26	30	Cell"	"SWAP - 70	44	53	Gene_or_gene_product"	"SWAP70	110	116	Gene_or_gene_product"	"colonies	132	140	Cell"	"SWAP - 70	158	167	Gene_or_gene_product"	"v - Src	216	223	Gene_or_gene_product"	"MEFs	236	240	Cell"	"[{""token"": ""v - Src"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEFs"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""SWAP - 70"", ""start_span"": 44, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""SWAP70"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""colonies"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Cell""}, {""token"": ""SWAP - 70"", ""start_span"": 158, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - Src"", ""start_span"": 216, ""end_span"": 223, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEFs"", ""start_span"": 236, ""end_span"": 240, ""type"": ""Cell""}]"
Consequently, we examined by immunohistochemistry, using the avidin - biotin - peroxidase method, Bcl - xL, Bax, and p53 expression in 56 samples of primary oral squamous cell carcinoma and in 22 matched pairs of primary and metastatic tumors.	"avidin	61	67	Gene_or_gene_product"	"biotin	70	76	Chemical"	"peroxidase	79	89	Gene_or_gene_product"	"Bcl - xL	98	106	Gene_or_gene_product"	"Bax	108	111	Gene_or_gene_product"	"p53	117	120	Gene_or_gene_product"	"oral squamous cell carcinoma	157	185	Cancer"	"metastatic tumors	225	242	Cancer"	"[{""token"": ""avidin"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""biotin"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Chemical""}, {""token"": ""peroxidase"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - xL"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""oral squamous cell carcinoma"", ""start_span"": 157, ""end_span"": 185, ""type"": ""Cancer""}, {""token"": ""metastatic tumors"", ""start_span"": 225, ""end_span"": 242, ""type"": ""Cancer""}]"
Treatment with the combination of 1B3 and DC101 in BxPC - 3 xenograft - bearing mice resulted in tumor regression in 58% of mice compared to that in 18% of mice treated with DC101 alone.	"1B3	34	37	Chemical"	"DC101	42	47	Chemical"	"BxPC - 3 xenograft	51	69	Cancer"	"mice	80	84	Organism"	"tumor	97	102	Cancer"	"mice	124	128	Organism"	"mice	156	160	Organism"	"DC101	174	179	Chemical"	"[{""token"": ""1B3"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""DC101"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Chemical""}, {""token"": ""BxPC - 3 xenograft"", ""start_span"": 51, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Organism""}, {""token"": ""mice"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Organism""}, {""token"": ""DC101"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Chemical""}]"
METHODS: Human fat tissue fragments from surgery were placed in 96 - well plates, embedded in fibrin thrombin clot and overlaid with cell culture media containing 20% fetal bovine serum.	"Human	9	14	Organism"	"fat tissue	15	25	Tissue"	"fibrin	94	100	Gene_or_gene_product"	"thrombin	101	109	Gene_or_gene_product"	"clot	110	114	Organism_substance"	"cell	133	137	Cell"	"bovine	173	179	Organism"	"serum	180	185	Organism_substance"	"[{""token"": ""Human"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Organism""}, {""token"": ""fat tissue"", ""start_span"": 15, ""end_span"": 25, ""type"": ""Tissue""}, {""token"": ""fibrin"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""clot"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Organism_substance""}, {""token"": ""cell"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Cell""}, {""token"": ""bovine"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Organism""}, {""token"": ""serum"", ""start_span"": 180, ""end_span"": 185, ""type"": ""Organism_substance""}]"
Acquired molecular abnormalities ( mutations or chromosomal translocations) of the RUNX1 transcription factor gene are frequent in acute myeloblastic leukemias ( AMLs) and in therapy - related myelodysplastic syndromes, but rarely in acute lymphoblastic leukemias ( ALLs) and chronic myelogenous leukemias ( CMLs).	"chromosomal	48	59	Cellular_component"	"RUNX1	83	88	Gene_or_gene_product"	"acute myeloblastic leukemias	131	159	Cancer"	"AMLs	162	166	Cancer"	"acute lymphoblastic leukemias	234	263	Cancer"	"ALLs	266	270	Cancer"	"chronic myelogenous leukemias	276	305	Cancer"	"CMLs	308	312	Cancer"	"[{""token"": ""chromosomal"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Cellular_component""}, {""token"": ""RUNX1"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""acute myeloblastic leukemias"", ""start_span"": 131, ""end_span"": 159, ""type"": ""Cancer""}, {""token"": ""AMLs"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Cancer""}, {""token"": ""acute lymphoblastic leukemias"", ""start_span"": 234, ""end_span"": 263, ""type"": ""Cancer""}, {""token"": ""ALLs"", ""start_span"": 266, ""end_span"": 270, ""type"": ""Cancer""}, {""token"": ""chronic myelogenous leukemias"", ""start_span"": 276, ""end_span"": 305, ""type"": ""Cancer""}, {""token"": ""CMLs"", ""start_span"": 308, ""end_span"": 312, ""type"": ""Cancer""}]"
In addition, we also report a high frequency of cryptic chromosomal RUNX1 translocation to a novel recently described gene partner, PRDM16 on chromosome 1p36, for 3 ( 21. 4%) of 14 investigated patients: 2 myeloid BC CMLs and, for the first time, 1 therapy - related BCR - ABL + ALL.	"chromosomal	56	67	Cellular_component"	"RUNX1	68	73	Gene_or_gene_product"	"PRDM16	132	138	Gene_or_gene_product"	"chromosome 1p36	142	157	Cellular_component"	"patients	194	202	Organism"	"myeloid BC CMLs	206	221	Cancer"	"BCR	267	270	Gene_or_gene_product"	"ABL	273	276	Gene_or_gene_product"	"[{""token"": ""chromosomal"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Cellular_component""}, {""token"": ""RUNX1"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""PRDM16"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""chromosome 1p36"", ""start_span"": 142, ""end_span"": 157, ""type"": ""Cellular_component""}, {""token"": ""patients"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Organism""}, {""token"": ""myeloid BC CMLs"", ""start_span"": 206, ""end_span"": 221, ""type"": ""Cancer""}, {""token"": ""BCR"", ""start_span"": 267, ""end_span"": 270, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Gene_or_gene_product""}]"
EXPERIMENTAL DESIGN: We used rAAV2 / 5 to deliver vasostatin intratumorally or systemically in different mouse lung tumor models - - subcutaneous, orthotopic xenograft, and spontaneous metastasis lung tumor models.	"rAAV2	29	34	Organism"	"5	37	38	Organism"	"vasostatin	50	60	Gene_or_gene_product"	"intratumorally	61	75	Cancer"	"mouse	105	110	Organism"	"lung tumor	111	121	Cancer"	"xenograft	158	167	Cancer"	"lung tumor	196	206	Cancer"	"[{""token"": ""rAAV2"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Organism""}, {""token"": ""5"", ""start_span"": 37, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""vasostatin"", ""start_span"": 50, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""intratumorally"", ""start_span"": 61, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Organism""}, {""token"": ""lung tumor"", ""start_span"": 111, ""end_span"": 121, ""type"": ""Cancer""}, {""token"": ""xenograft"", ""start_span"": 158, ""end_span"": 167, ""type"": ""Cancer""}, {""token"": ""lung tumor"", ""start_span"": 196, ""end_span"": 206, ""type"": ""Cancer""}]"
We did a blind prospective study in gastric cancer to assess the significance of isolated tumor cells ( ITC) and to test the hypothesis that vascular endothelial growth factor receptor - 1 ( VEGFR - 1) is expressed within the bone marrow at tumor - specific, premetastatic sites.	"gastric cancer	36	50	Cancer"	"isolated tumor cells	81	101	Cell"	"ITC	104	107	Cell"	"vascular endothelial growth factor receptor - 1	141	188	Gene_or_gene_product"	"VEGFR - 1	191	200	Gene_or_gene_product"	"bone marrow	226	237	Multi"	"tumor	241	246	Cancer"	"premetastatic sites	259	278	Multi"	"[{""token"": ""gastric cancer"", ""start_span"": 36, ""end_span"": 50, ""type"": ""Cancer""}, {""token"": ""isolated tumor cells"", ""start_span"": 81, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""ITC"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor receptor - 1"", ""start_span"": 141, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 1"", ""start_span"": 191, ""end_span"": 200, ""type"": ""Gene_or_gene_product""}, {""token"": ""bone marrow"", ""start_span"": 226, ""end_span"": 237, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 241, ""end_span"": 246, ""type"": ""Cancer""}, {""token"": ""premetastatic sites"", ""start_span"": 259, ""end_span"": 278, ""type"": ""Multi""}]"
We previously reported that a single dose of ethanol ( 1. 4 g / kg), yielding a blood alcohol concentration of 100 mg / dl, significantly impairs angiogenesis in murine wounds, despite adequate levels of VEGF, suggesting direct effects of ethanol on endothelial cell signaling ( 40).	"ethanol	45	52	Chemical"	"blood	80	85	Organism_substance"	"alcohol	86	93	Chemical"	"murine	162	168	Organism"	"wounds	169	175	Pathological_formation"	"VEGF	204	208	Gene_or_gene_product"	"ethanol	239	246	Chemical"	"endothelial cell	250	266	Cell"	"[{""token"": ""ethanol"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""blood"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism_substance""}, {""token"": ""alcohol"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""murine"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Organism""}, {""token"": ""wounds"", ""start_span"": 169, ""end_span"": 175, ""type"": ""Pathological_formation""}, {""token"": ""VEGF"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""ethanol"", ""start_span"": 239, ""end_span"": 246, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 250, ""end_span"": 266, ""type"": ""Cell""}]"
Four weeks after cell transplantation, reverse transcriptase - polymerase chain reaction ( RT - PCR) and immunohistochemistry for vascular endothelial growth factor ( VEGF), VIII - factor immunohistochemistry for vessel density, TUNEL, caspase - 3 for cardiomyocyte apoptosis, echocardiography and hemodynamic detection for heart function were performed.	"cell	17	21	Cell"	"vascular endothelial growth factor	130	164	Gene_or_gene_product"	"VEGF	167	171	Gene_or_gene_product"	"VIII - factor	174	187	Gene_or_gene_product"	"vessel	213	219	Multi"	"caspase - 3	236	247	Gene_or_gene_product"	"cardiomyocyte	252	265	Cell"	"heart	324	329	Organ"	"[{""token"": ""cell"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 130, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""VIII - factor"", ""start_span"": 174, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}, {""token"": ""vessel"", ""start_span"": 213, ""end_span"": 219, ""type"": ""Multi""}, {""token"": ""caspase - 3"", ""start_span"": 236, ""end_span"": 247, ""type"": ""Gene_or_gene_product""}, {""token"": ""cardiomyocyte"", ""start_span"": 252, ""end_span"": 265, ""type"": ""Cell""}, {""token"": ""heart"", ""start_span"": 324, ""end_span"": 329, ""type"": ""Organ""}]"
Treatment of cultured human endothelial cells with DAPT, a gamma secretase inhibitor, increased cell migration and sprout formation in response to VEGF stimulation with a biphasic dependence on DAPT concentration.	"human	22	27	Organism"	"endothelial cells	28	45	Cell"	"DAPT	51	55	Chemical"	"gamma secretase	59	74	Gene_or_gene_product"	"cell	96	100	Cell"	"sprout	115	121	Tissue"	"VEGF	147	151	Gene_or_gene_product"	"DAPT	194	198	Chemical"	"[{""token"": ""human"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Organism""}, {""token"": ""endothelial cells"", ""start_span"": 28, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""DAPT"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""gamma secretase"", ""start_span"": 59, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""sprout"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Tissue""}, {""token"": ""VEGF"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""DAPT"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Chemical""}]"
Further, delivery of an appropriate combination of DAPT and VEGF from an injectable alginate hydrogel system into ischemic hindlimbs led to a faster recovery of blood flow than VEGF or DAPT alone; perfusion levels reached 80% of the normal level by week 4 with combined DAPT and VEGF delivery.	"DAPT	51	55	Chemical"	"VEGF	60	64	Gene_or_gene_product"	"hindlimbs	123	132	Organism_subdivision"	"blood	161	166	Organism_substance"	"VEGF	177	181	Gene_or_gene_product"	"DAPT	185	189	Chemical"	"DAPT	270	274	Chemical"	"VEGF	279	283	Gene_or_gene_product"	"[{""token"": ""DAPT"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""hindlimbs"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Organism_subdivision""}, {""token"": ""blood"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Organism_substance""}, {""token"": ""VEGF"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""DAPT"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Chemical""}, {""token"": ""DAPT"", ""start_span"": 270, ""end_span"": 274, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 279, ""end_span"": 283, ""type"": ""Gene_or_gene_product""}]"
Based on our results, we hypothesize that FGFR2 ( +) - TFs might provide cancer cells with a suitable microenvironment via secretion of proteins that could promote cancer development and progression through stimulation of cancer cell proliferation, induction of angiogenesis, inhibition of cell adhesion, enhancement of cell mobility, and promotion of the epithelial - mesenchymal transition.	"FGFR2	42	47	Gene_or_gene_product"	"cancer cells	73	85	Cell"	"cancer	164	170	Cancer"	"cancer cell	222	233	Cell"	"cell	290	294	Cell"	"cell	320	324	Cell"	"epithelial	356	366	Cell"	"mesenchymal	369	380	Cell"	"[{""token"": ""FGFR2"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 73, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Cancer""}, {""token"": ""cancer cell"", ""start_span"": 222, ""end_span"": 233, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 290, ""end_span"": 294, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 320, ""end_span"": 324, ""type"": ""Cell""}, {""token"": ""epithelial"", ""start_span"": 356, ""end_span"": 366, ""type"": ""Cell""}, {""token"": ""mesenchymal"", ""start_span"": 369, ""end_span"": 380, ""type"": ""Cell""}]"
The aims of the present study were to compare, in vitro and in vivo, the antiangiogenic and antitumor activities of metronomic irinotecan ( CPT - 11), oxaliplatin ( L - OHP) and 5 - fluorouracil ( 5 - FU) in colorectal cancer and to investigate the metronomic combination of these drugs.	"antitumor	92	101	Cancer"	"irinotecan	127	137	Chemical"	"CPT - 11	140	148	Chemical"	"oxaliplatin	151	162	Chemical"	"L - OHP	165	172	Chemical"	"5 - fluorouracil	178	194	Chemical"	"5 - FU	197	203	Chemical"	"colorectal cancer	208	225	Cancer"	"[{""token"": ""antitumor"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Cancer""}, {""token"": ""irinotecan"", ""start_span"": 127, ""end_span"": 137, ""type"": ""Chemical""}, {""token"": ""CPT - 11"", ""start_span"": 140, ""end_span"": 148, ""type"": ""Chemical""}, {""token"": ""oxaliplatin"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Chemical""}, {""token"": ""L - OHP"", ""start_span"": 165, ""end_span"": 172, ""type"": ""Chemical""}, {""token"": ""5 - fluorouracil"", ""start_span"": 178, ""end_span"": 194, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 197, ""end_span"": 203, ""type"": ""Chemical""}, {""token"": ""colorectal cancer"", ""start_span"": 208, ""end_span"": 225, ""type"": ""Cancer""}]"
In these breast cancers activated Akt fails to inactivate and re - localize FOXO3a to the cytoplasm, and nuclear - targeted FOXO3a does not induce cell death or cell cycle arrest.	"breast cancers	9	23	Cancer"	"Akt	34	37	Gene_or_gene_product"	"FOXO3a	76	82	Gene_or_gene_product"	"cytoplasm	90	99	Organism_substance"	"nuclear	105	112	Cellular_component"	"FOXO3a	124	130	Gene_or_gene_product"	"cell	147	151	Cell"	"cell	161	165	Cell"	"[{""token"": ""breast cancers"", ""start_span"": 9, ""end_span"": 23, ""type"": ""Cancer""}, {""token"": ""Akt"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""FOXO3a"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoplasm"", ""start_span"": 90, ""end_span"": 99, ""type"": ""Organism_substance""}, {""token"": ""nuclear"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Cellular_component""}, {""token"": ""FOXO3a"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Cell""}]"
We have established a model system to detect the presence of ras p21 in the sera of Balb / c mice carrying tumors induced by a mouse cell line transformed with the Harvey murine sarcoma virus in the presence of a helper Friend murine leukemia virus.	"ras p21	61	68	Gene_or_gene_product"	"sera	76	80	Organism_substance"	"Balb / c mice	84	97	Organism"	"tumors	107	113	Cancer"	"mouse	127	132	Organism"	"cell line	133	142	Cell"	"Harvey murine sarcoma virus	164	191	Organism"	"Friend murine leukemia virus	220	248	Organism"	"[{""token"": ""ras p21"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""sera"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Organism_substance""}, {""token"": ""Balb / c mice"", ""start_span"": 84, ""end_span"": 97, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Organism""}, {""token"": ""cell line"", ""start_span"": 133, ""end_span"": 142, ""type"": ""Cell""}, {""token"": ""Harvey murine sarcoma virus"", ""start_span"": 164, ""end_span"": 191, ""type"": ""Organism""}, {""token"": ""Friend murine leukemia virus"", ""start_span"": 220, ""end_span"": 248, ""type"": ""Organism""}]"
Since ras genes have been found to be frequently activated in human tumours, we examined the levels of ras p21 in the sera of a variety of human cancer patients.	"ras	6	9	Gene_or_gene_product"	"human	62	67	Organism"	"tumours	68	75	Cancer"	"ras p21	103	110	Gene_or_gene_product"	"sera	118	122	Organism_substance"	"human	139	144	Organism"	"cancer	145	151	Cancer"	"patients	152	160	Organism"	"[{""token"": ""ras"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""tumours"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""ras p21"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""sera"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Organism_substance""}, {""token"": ""human"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Organism""}]"
We concluded that RAF265 is highly efficacious in this xenograft model of human melanoma and decreases glucose metabolism as measured by DNA microarray analysis, cell culture assays, and small animal FDG PET scans as early as 1 day after treatment.	"RAF265	18	24	Chemical"	"xenograft	55	64	Cancer"	"human	74	79	Organism"	"melanoma	80	88	Cancer"	"glucose	103	110	Chemical"	"DNA	137	140	Cellular_component"	"cell	162	166	Cell"	"FDG	200	203	Chemical"	"[{""token"": ""RAF265"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""xenograft"", ""start_span"": 55, ""end_span"": 64, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Organism""}, {""token"": ""melanoma"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Cancer""}, {""token"": ""glucose"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Cell""}, {""token"": ""FDG"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Chemical""}]"
Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2 / Akt / mTOR / S6K1 pathways through modulation of Bcl - 2 and BAD.	"Sunitinib	0	9	Chemical"	"pheochromocytoma tumor cells	31	59	Cell"	"VEGFR2	74	80	Gene_or_gene_product"	"Akt	83	86	Gene_or_gene_product"	"mTOR	89	93	Gene_or_gene_product"	"S6K1	96	100	Gene_or_gene_product"	"Bcl - 2	132	139	Gene_or_gene_product"	"BAD	144	147	Gene_or_gene_product"	"[{""token"": ""Sunitinib"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""pheochromocytoma tumor cells"", ""start_span"": 31, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""VEGFR2"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""S6K1"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAD"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"
Thus, these results together suggest that sunitinib initially exerts its apoptotic effect through the inhibition of VEGFR - 2, which, when followed by reduction of its downstream effectors, including Akt / mTOR / S6K1, may lead to inhibition of the antiapoptotic molecule Bcl - 2 and activation of the proapoptotic molecule BAD in PC12 cells.	"sunitinib	42	51	Chemical"	"VEGFR - 2	116	125	Gene_or_gene_product"	"Akt	200	203	Gene_or_gene_product"	"mTOR	206	210	Gene_or_gene_product"	"S6K1	213	217	Gene_or_gene_product"	"Bcl - 2	272	279	Gene_or_gene_product"	"BAD	324	327	Gene_or_gene_product"	"PC12 cells	331	341	Cell"	"[{""token"": ""sunitinib"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""VEGFR - 2"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene_or_gene_product""}, {""token"": ""S6K1"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 272, ""end_span"": 279, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAD"", ""start_span"": 324, ""end_span"": 327, ""type"": ""Gene_or_gene_product""}, {""token"": ""PC12 cells"", ""start_span"": 331, ""end_span"": 341, ""type"": ""Cell""}]"
Using isogenic human mammary epithelial cells ( HMEC) at different stages of neoplastic transformation, we found that OSM signaling suppressed c - MYC expression and engaged a p16 - and p53 - independent growth arrest that required STAT3 activity.	"human	15	20	Organism"	"mammary epithelial cells	21	45	Cell"	"HMEC	48	52	Cell"	"OSM	118	121	Gene_or_gene_product"	"c - MYC	143	150	Gene_or_gene_product"	"p16	176	179	Gene_or_gene_product"	"p53	186	189	Gene_or_gene_product"	"STAT3	232	237	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Organism""}, {""token"": ""mammary epithelial cells"", ""start_span"": 21, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""HMEC"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""OSM"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - MYC"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""p16"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""STAT3"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}]"
Pthrp ablation in the mammary epithelium of the PyMT - MMTV breast cancer mouse model caused a delay in primary tumor initiation, inhibited tumor progression, and reduced metastasis to distal sites.	"Pthrp	0	5	Gene_or_gene_product"	"mammary epithelium	22	40	Tissue"	"PyMT	48	52	Gene_or_gene_product"	"MMTV	55	59	Organism"	"breast cancer	60	73	Cancer"	"mouse	74	79	Organism"	"tumor	112	117	Cancer"	"tumor	140	145	Cancer"	"[{""token"": ""Pthrp"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammary epithelium"", ""start_span"": 22, ""end_span"": 40, ""type"": ""Tissue""}, {""token"": ""PyMT"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMTV"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 60, ""end_span"": 73, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Cancer""}]"
The antiproliferative and anti - migratory mechanisms of HTPB were investigated by cell proliferation, flow cytometry, DNA ladder, caspase activity, Rho activity, F - actin polymerization, and gelatin - zymography for matrix metalloproteinases ( MMPs).	"HTPB	57	61	Chemical"	"cell	83	87	Cell"	"DNA	119	122	Cellular_component"	"caspase	131	138	Gene_or_gene_product"	"Rho	149	152	Gene_or_gene_product"	"F - actin	163	172	Gene_or_gene_product"	"matrix metalloproteinases	218	243	Gene_or_gene_product"	"MMPs	246	250	Gene_or_gene_product"	"[{""token"": ""HTPB"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Cellular_component""}, {""token"": ""caspase"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rho"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""F - actin"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinases"", ""start_span"": 218, ""end_span"": 243, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMPs"", ""start_span"": 246, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}]"
The B ( 1) R appeared either as cytoplasmic dots or labeling on the apical cell membrane of the cells composing the epithelia with intestinal metaplasia ( 24 / 24; 100%) and carcinoma in situ ( 10 / 10; 100%) and in the epithelial cells of adenomas.	"cytoplasmic	32	43	Organism_substance"	"apical cell membrane	68	88	Cellular_component"	"cells	96	101	Cell"	"epithelia	116	125	Tissue"	"intestinal metaplasia	131	152	Cancer"	"carcinoma in situ	174	191	Cancer"	"epithelial cells	220	236	Cell"	"adenomas	240	248	Cancer"	"[{""token"": ""cytoplasmic"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Organism_substance""}, {""token"": ""apical cell membrane"", ""start_span"": 68, ""end_span"": 88, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""epithelia"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Tissue""}, {""token"": ""intestinal metaplasia"", ""start_span"": 131, ""end_span"": 152, ""type"": ""Cancer""}, {""token"": ""carcinoma in situ"", ""start_span"": 174, ""end_span"": 191, ""type"": ""Cancer""}, {""token"": ""epithelial cells"", ""start_span"": 220, ""end_span"": 236, ""type"": ""Cell""}, {""token"": ""adenomas"", ""start_span"": 240, ""end_span"": 248, ""type"": ""Cancer""}]"
Expression of bFGF on normal human tissues was ubiquitously detected in the basement membranes of all size blood vessels, but was not found in epidermal or epithelial basement membranes of a variety of tissues tested.	"bFGF	14	18	Gene_or_gene_product"	"human	29	34	Organism"	"tissues	35	42	Tissue"	"basement membranes	76	94	Cellular_component"	"blood vessels	107	120	Multi"	"epidermal	143	152	Cellular_component"	"epithelial basement membranes	156	185	Cellular_component"	"tissues	202	209	Tissue"	"[{""token"": ""bFGF"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Organism""}, {""token"": ""tissues"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Tissue""}, {""token"": ""basement membranes"", ""start_span"": 76, ""end_span"": 94, ""type"": ""Cellular_component""}, {""token"": ""blood vessels"", ""start_span"": 107, ""end_span"": 120, ""type"": ""Multi""}, {""token"": ""epidermal"", ""start_span"": 143, ""end_span"": 152, ""type"": ""Cellular_component""}, {""token"": ""epithelial basement membranes"", ""start_span"": 156, ""end_span"": 185, ""type"": ""Cellular_component""}, {""token"": ""tissues"", ""start_span"": 202, ""end_span"": 209, ""type"": ""Tissue""}]"
In contrast, no leukemia was observed with a myb IRES virus, with spliced vectors containing v - erbA alone or v - erbA in combination with v - myb, nor with erbA IRES and erbA / myb IRES viruses produced in the absence of helper virus.	"leukemia	16	24	Cancer"	"myb	45	48	Gene_or_gene_product"	"v - erbA	93	101	Gene_or_gene_product"	"v - erbA	111	119	Gene_or_gene_product"	"v - myb	140	147	Gene_or_gene_product"	"erbA	158	162	Gene_or_gene_product"	"erbA	172	176	Gene_or_gene_product"	"myb	179	182	Gene_or_gene_product"	"[{""token"": ""leukemia"", ""start_span"": 16, ""end_span"": 24, ""type"": ""Cancer""}, {""token"": ""myb"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - erbA"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - erbA"", ""start_span"": 111, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - myb"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""erbA"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""erbA"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""myb"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}]"
Lysates of cells from the granulocyte - macrophage colony - stimulating factor ( GM - CSF) - dependent myeloid leukemic cell line TF1 were separated into high molecular weight ( HMW) pellets of intact DNA and supernatants of fragmented low MW ( LMW) DNA, and the DNA purified from these fractions was quantified.	"Lysates	0	7	Organism_substance"	"cells	11	16	Cell"	"granulocyte - macrophage colony - stimulating factor	26	78	Gene_or_gene_product"	"GM - CSF	81	89	Gene_or_gene_product"	"myeloid leukemic cell line TF1	103	133	Cell"	"DNA	201	204	Cellular_component"	"DNA	250	253	Cellular_component"	"DNA	263	266	Cellular_component"	"[{""token"": ""Lysates"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Organism_substance""}, {""token"": ""cells"", ""start_span"": 11, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 26, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""GM - CSF"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid leukemic cell line TF1"", ""start_span"": 103, ""end_span"": 133, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 201, ""end_span"": 204, ""type"": ""Cellular_component""}, {""token"": ""DNA"", ""start_span"": 250, ""end_span"": 253, ""type"": ""Cellular_component""}, {""token"": ""DNA"", ""start_span"": 263, ""end_span"": 266, ""type"": ""Cellular_component""}]"
Thus, these data demonstrate cooperative mechanisms for VPF / VEGF regulation of EC migration involving the alphavbeta3 integrin, the alphavbeta3 ligand OPN, and thrombin cleavage of OPN.	"VPF	56	59	Gene_or_gene_product"	"VEGF	62	66	Gene_or_gene_product"	"EC	81	83	Cell"	"alphavbeta3 integrin	108	128	Gene_or_gene_product"	"alphavbeta3	134	145	Gene_or_gene_product"	"OPN	153	156	Gene_or_gene_product"	"thrombin	162	170	Gene_or_gene_product"	"OPN	183	186	Gene_or_gene_product"	"[{""token"": ""VPF"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 81, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""alphavbeta3 integrin"", ""start_span"": 108, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""alphavbeta3"", ""start_span"": 134, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPN"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPN"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}]"
We demonstrate directly that the wild - type 55 - kDa protein is able to block E1A - induced p53 - dependent apoptosis, whereas cells infected by mutant pm490 / 1 / 5A, which contains alanine residues at all three phosphorylation sites, exhibited extensive DNA fragmentation and classic apoptotic cell death.	"55 - kDa	45	53	Gene_or_gene_product"	"E1A	79	82	Gene_or_gene_product"	"p53	93	96	Gene_or_gene_product"	"cells	128	133	Cell"	"mutant pm490 / 1 / 5A	146	167	Organism"	"alanine	184	191	Amino_acid"	"DNA	257	260	Cellular_component"	"cell	297	301	Cell"	"[{""token"": ""55 - kDa"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""E1A"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Cell""}, {""token"": ""mutant pm490 / 1 / 5A"", ""start_span"": 146, ""end_span"": 167, ""type"": ""Organism""}, {""token"": ""alanine"", ""start_span"": 184, ""end_span"": 191, ""type"": ""Amino_acid""}, {""token"": ""DNA"", ""start_span"": 257, ""end_span"": 260, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 297, ""end_span"": 301, ""type"": ""Cell""}]"
Assuming discrimination thresholds between high - grade and low - grade tumours of 0. 8 for 18F - FDG uptake and 1. 8 for 123I - IMT uptake, the accuracy values of 18F - FDG PET and 123I - IMT SPET for differentiating between high - grade and low - grade tumours were 21 / 23 ( 91%) and 19 / 23 ( 83%), respectively.	"high - grade	43	55	Cancer"	"low - grade tumours	60	79	Cancer"	"18F - FDG	92	101	Chemical"	"123I - IMT	122	132	Chemical"	"18F - FDG	164	173	Chemical"	"123I - IMT	182	192	Chemical"	"high - grade	226	238	Cancer"	"low - grade tumours	243	262	Cancer"	"[{""token"": ""high - grade"", ""start_span"": 43, ""end_span"": 55, ""type"": ""Cancer""}, {""token"": ""low - grade tumours"", ""start_span"": 60, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""18F - FDG"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Chemical""}, {""token"": ""123I - IMT"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Chemical""}, {""token"": ""18F - FDG"", ""start_span"": 164, ""end_span"": 173, ""type"": ""Chemical""}, {""token"": ""123I - IMT"", ""start_span"": 182, ""end_span"": 192, ""type"": ""Chemical""}, {""token"": ""high - grade"", ""start_span"": 226, ""end_span"": 238, ""type"": ""Cancer""}, {""token"": ""low - grade tumours"", ""start_span"": 243, ""end_span"": 262, ""type"": ""Cancer""}]"
The primary results indicated ( i) positive results of in situ hybridization are presence of granules or masses in the cytoplasm; ( ii) the less expression of nm23 - H1 mRNA, the higher metastatic rate of the human hepatocellular carcinoma ( P < 0. 05); ( iii) expression of nm23 - H1 mRNA dose not correlate with some other factors such as tumor size and the background of other liver diseases.	"granules	93	101	Cellular_component"	"cytoplasm	119	128	Organism_substance"	"nm23 - H1	159	168	Gene_or_gene_product"	"human	209	214	Organism"	"hepatocellular carcinoma	215	239	Cancer"	"nm23 - H1	275	284	Gene_or_gene_product"	"tumor	341	346	Cancer"	"liver	380	385	Organ"	"[{""token"": ""granules"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Cellular_component""}, {""token"": ""cytoplasm"", ""start_span"": 119, ""end_span"": 128, ""type"": ""Organism_substance""}, {""token"": ""nm23 - H1"", ""start_span"": 159, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 209, ""end_span"": 214, ""type"": ""Organism""}, {""token"": ""hepatocellular carcinoma"", ""start_span"": 215, ""end_span"": 239, ""type"": ""Cancer""}, {""token"": ""nm23 - H1"", ""start_span"": 275, ""end_span"": 284, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 341, ""end_span"": 346, ""type"": ""Cancer""}, {""token"": ""liver"", ""start_span"": 380, ""end_span"": 385, ""type"": ""Organ""}]"
We produced a transgenic mouse line that expresses simian virus ( SV40) transforming sequences under control of the 1. 4 kb tyrosinase - related protein 1 ( TRP - 1) promoter, targeting expression of T antigen ( Tag) to the RPE.	"mouse	25	30	Organism"	"simian virus	51	63	Organism"	"SV40	66	70	Organism"	"tyrosinase - related protein 1	124	154	Gene_or_gene_product"	"TRP - 1	157	164	Gene_or_gene_product"	"T antigen	200	209	Gene_or_gene_product"	"Tag	212	215	Gene_or_gene_product"	"RPE	224	227	Tissue"	"[{""token"": ""mouse"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Organism""}, {""token"": ""simian virus"", ""start_span"": 51, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""SV40"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Organism""}, {""token"": ""tyrosinase - related protein 1"", ""start_span"": 124, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRP - 1"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""T antigen"", ""start_span"": 200, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tag"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}, {""token"": ""RPE"", ""start_span"": 224, ""end_span"": 227, ""type"": ""Tissue""}]"
